Conference Menu

Current Event 

Overview 
Short Courses
Part One
Combined Session
Part Two
Faculty
Delegate List
Speaker Interviews
Sponsorship
Hotel and Travel
PDF Download
Poster
Press Pass 
Request Brochure 
Archives 

DVDs 

Corporate Sponsors:

Meso Scale 

Phadia 

Corporate Support Sponsor:

BioAgilytix Labs 

Lead Sponsoring Publications:

Bio-IT World 

Nature 

Science AAAS logo 

The Scientist 

Sponsoring Publications:

Bio Pharm Intl 

Future Medicine 

Insight Pharma Reports 

PharmaVoice 

Web Partners:

Pharm Cast 

Pharmaphorum 

SelectScience.net 


Immunogenicity Summit 2011 - Distinguished Faculty

Conference Proceeding CD Now Available
  • Speaker Presentations
  • Poster Abstracts
  • and More!

Part One: IMMUNOGENICITY ASSESSMENT AND CLINICAL RELEVANCE


Melissa Cheu, Senior Research Associate, Bioanalytical Assays, Genentech, Inc.


Deborah Finco, Ph.D., Immunogenicity Lead, Immunotoxicology COE, Drug Safety R&D, Pfizer, Inc.


Robert G. Hamilton, Ph.D., D.ABMLI, Professor, Medicine and Pathology, Johns Hopkins University School of Medicine, and Director, Johns Hopkins Dermatology, Allergy and Clinical Immunology Reference Laboratory


Kristina Howard, Therapeutic Proteins, FDA


Steve Keller, Ph.D., Director, Bioanalytical Sciences, Abbott Biotherapeutics


Susan Richards, Ph.D., Group Vice President, Clinical Laboratory Science, Biologics R&D, Genzyme Corp.


Holly W. Smith, B.A., Senior Research Scientist, Investigative Toxicology, Eli Lilly and Company


Meena Subramanyam, Ph.D., Senior Director, Clinical Science & Technology, Biogen Idec, Inc.


Albert Torri, Ph.D., Senior Director, Bioanalytical Sciences, Regeneron Pharmaceuticals


Michael Tovey, Ph.D., Director, Research, Biotechnology & Applied Pharmacology, ENS Cachan


Marie T. Rock, Ph.D., Vice President, Protein Bioanalysis, Midwest BioResearch LLC, a Wil Research Company


Sam Song, M.D., Senior Scientist, Immunoassay Development, Merrimack Pharmaceuticals, Inc.


Tobias Manigold, M.D., Lab Head, Immunosafety, Hoffmann-La Roche


Jörgen Dahlström, Ph.D., Scientific Director, Phadia


Matthias Hofmann, Ph.D., Senior Investigator, Bioanalytics, Novartis Institutes for Biomedical Research


Daniel T. Mytych, Ph.D., Principal Scientist, Clinical Immunology, Amgen, Inc.


Marie T. Rock, Ph.D., Vice President, Immunoassays, Midwest BioResearch, a Wil Research Company

Stephen Keller, Ph.D., Associate Director, Pre-Clinical and Clinical Development Sciences, Abbott Biotherapeutics Corp.

Sally Fischer, Ph.D., Senior Scientist & Group Leader, Bioanalytical Research and Development (BARD), Genentech, Inc.

Pankaj Oberoi, Ph.D., Director, Scientific Services and Research & Development, Meso Scale Discovery

Brian Schlain, Lead, Non-Clinical Statistician, Biostatistics, Biogen Idec, Inc.


Combined Session 


Susan Kirshner, Associate Chief, Laboratory of Immunology, Office of Biotechnology, FDA


Robin Thorpe, Ph.D., FRCPath., Head, Biotherapeutics Group, NIBSC


Meena Subramanyam, Ph.D., Senior Director, Clinical Science & Technology, Biogen Idec, Inc.


Ethan M. Shevach, M.D., Chief, Cellular Immunology Section, Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health


 


Part Two: IMMUNOGENICITY PREDICTION AND MITIGATION

Michel Awwad, Senior Director, PDM-NBE, Pfizer, Inc.

 

Matthew Baker, Ph.D., CSO, Antitope Ltd.


Mary Cromwell, Ph.D., Senior Scientist & Associate Director, Protein Analytical Chemistry, Genentech, Inc.


John Den Engelsman, Merck, Sharpe & Dohme


Fiona A. Harding, Ph.D., Senior Principal Research Scientist, Biologics Technologies, Abbott Biotherapeutics Corp.


Sandeep Kumar, Principal Scientist, Biotherapeutics Pharmaceutical Sciences, Pfizer, Inc.


Nadine Ritter, Ph.D., Senior CMC Consultant, Biologics Consulting Group, Inc.


David W. Scott, Ph.D., Professor and Vice Chair for Research, Department of Medicine, Uniformed Services University of Health Sciences, Bethesda


Daniela Verthelyi, M.D., Ph.D., Chief, Laboratory of Immunology, Therapeutic Proteins, CDER, FDA


Susan Kirshner, Ph.D., Associate Chief, Laboratory of Immunology, Therapeutic Proteins, Biotechnology, FDA

Kristina Howard, D.V.M., Ph.D., FDA Commissioner’s Fellow, Therapeutic Proteins, Pharmaceutical Sciences, CDER, FDA

Melody Sauerborn. Ph.D., Pharmaceutical Sciences, University of Utrecht, and CEO, ADA InVivo BV

Miranda van Beers, Ph.D., Research Scientist, Analytics, Bioprocessing Technology Institute, A*STAR




By Series:
By Region: